コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 both to addictive behaviors and drug-induced brain damage.
2 for prognostic purposes and to assess early brain damage.
3 ous in reducing LPS-induced hypoxic-ischemic brain damage.
4 spreading depression (CSD), which aggravates brain damage.
5 fibrosis and protected against hydrocephalic brain damage.
6 etworks that can be individually impaired by brain damage.
7 ines, leading to the exacerbation of primary brain damage.
8 n modulate attentional impairments following brain damage.
9 orms, NCX1, NCX2, and NCX3, worsens ischemic brain damage.
10 tor molecule-1 (TRIF) did not develop larger brain damage.
11 structural MR imaging markers of subclinical brain damage.
12 tentional impairments in patients with focal brain damage.
13 but also strongly protected against ischemic brain damage.
14 ickly enough with anticonvulsants to prevent brain damage.
15 eizures, or gross or microscopic evidence of brain damage.
16 symptoms; the brain MRIs indicating diffuse brain damage.
17 type W (HERV-W) contributes significantly to brain damage.
18 face recognition deficits in the absence of brain damage.
19 e microRNAs after cardiac arrest may reflect brain damage.
20 function to reduce ischemia-induced hypoxic brain damage.
21 cerebral inflammation and limiting secondary brain damage.
22 we have developed for autoantibody-mediated brain damage.
23 ood flow and significantly reducing ischemic brain damage.
24 f cerebral edema further contributes towards brain damage.
25 since the injury or the extent of structural brain damage.
26 rapeutically targeted to minimize poststroke brain damage.
27 the pathogen from circulation and prevented brain damage.
28 e right-hemisphere following left-hemisphere brain damage.
29 ) was associated with multiple indicators of brain damage.
30 causing swelling of the head and potentially brain damage.
31 st postnatal days and indicators of neonatal brain damage.
32 of motor function in pre-clinical models of brain damage.
33 r derangements that might also contribute to brain damage.
34 maged neurons to form axon collaterals after brain damage.
35 as part of the host inflammatory response to brain damage.
36 terious immune responses and limit bystander brain damage.
37 induce brain Hp is linked to a reduction in brain damage.
38 exacerbates transient focal ischemia-induced brain damage.
39 thus, may result in an increase in ischemic brain damage.
40 and middle cerebral artery occlusion-induced brain damage.
41 r time in children with perinatal unilateral brain damage.
42 sumption on transient focal ischemia-induced brain damage.
43 icular injection of tPA increased HI-induced brain damage.
44 utes to the pathogenesis of hypoxic-ischemic brain damage.
45 ortant functions in many aspects of ischemic brain damage.
46 ism may explain why inhibition of XO reduces brain damage.
47 tective mechanisms that can prevent or limit brain damage.
48 opics ranging from learning to recovery from brain damage.
49 hypoxanthine nor xanthine infusion increased brain damage.
50 w three main roles of astrocytes in ischemic brain damage.
51 strate at the time of injury should increase brain damage.
52 or antagonist abolished the effect of LPS on brain damage.
53 ary acidic protein (GFAP) is associated with brain damage.
54 ediate layers of the SC contralateral to the brain damage.
55 ng destructive molecules that may exacerbate brain damage.
56 cerebral ischemia, significantly aggravates brain damage.
57 induced microvascular thrombus formation and brain damage.
58 al therapeutic target to minimize poststroke brain damage.
59 ce of diffuse vascular and neurodegenerative brain damage.
60 ing in postnatal microcephaly with extensive brain damage.
61 y cells invading the brain lead to secondary brain damage.
62 of high-level visual cortex following focal brain damage.
63 rophages and consequently increases ischemic brain damage.
64 nts the development of clinical symptoms and brain damage.
65 y identify a new therapeutic window to limit brain damage.
66 satory mechanisms used by patients following brain damage.
67 e has been implicated in the pathogenesis of brain damage.
68 verlapping and syndrome-specific patterns of brain damage.
69 rapeutically targeted to minimize poststroke brain damage.
70 modulates poststroke behavioral deficits and brain damage.
71 EST-downstream genes might modulate ischemic brain damage.
72 ding better compensation or resilience after brain damage.
73 infants with MoCD and prevents irreversible brain damage.
74 lly seen in dystonia secondary to structural brain damage.
75 tions can lead to cold sores, blindness, and brain damage.
76 itive function even with a certain amount of brain damages.
77 tality apart from a reduction in the fear of brain damage (-0.0185, CI -0.0313 to -0.0057, p=0.0046)
79 ted mice had a significantly lower volume of brain damage (13+/-7 mm(3), p<0.01) than both control gr
82 rs of injury significantly reduced secondary brain damage (30 mins: 25 mm vs. vehicle: 41 mm) and imp
83 ysfunction, potentially leading to permanent brain damage, a condition known as kernicterus Although
84 , DANGER-deficient mice manifest more severe brain damage after acute excitotoxicity and transient ce
87 t an L-kynurenine/AhR pathway mediates acute brain damage after stroke and open new possibilities for
89 Importantly, examination of patients with brain damage allows one to draw conclusions about whethe
91 sociation with improved motor function after brain damage and amphetamine treatment linked with rehab
96 this issue, the current study examined frank brain damage and changes in cortical activation as predi
98 onsible for the accumulation of irreversible brain damage and for the development of innovative thera
102 candesartan afforded sustained reduction of brain damage and improved neurologic function 5 days aft
104 h often runs in families, have no history of brain damage and intact early visual processing systems.
105 ve STEP during reperfusion precedes ischemic brain damage and is associated with secondary activation
108 ient female mice showed a marked increase in brain damage and long-lasting learning deficits, whereas
109 ity into the brain, microvascular structural brain damage and lower scores in various cognitive domai
110 ical conditions result from diverse areas of brain damage and may have different underlying causes.
111 zzle of the relationship between PrP(Sc) and brain damage and may in part explain the mechanism of pr
112 the effect of neonatal hypoxic-ischemic (HI) brain damage and mesenchymal stem cell (MSC) treatment o
113 nduce intracerebral hemorrhage caused marked brain damage and modified the levels of inflammatory mar
114 tudied whether alpha-Syn mediates poststroke brain damage and more importantly whether preventing alp
116 chemia/reperfusion injury, and the amount of brain damage and neurological deficits caused by a strok
117 ce are profoundly protected from excitotoxic brain damage and neurological deficits following experim
119 these mice to experience significantly more brain damage and oxidative stress in response to middle
123 ompared with controls, due to a reduction in brain damage and reduced accumulation of amyloid beta ag
125 s with acquired cognitive deficits following brain damage and studies using contemporary neuroimaging
126 drial iron in the pathogenesis of SE-induced brain damage and subcellular iron chelation as a novel t
127 l hypoxia-ischemia (HI) is a common cause of brain damage and subsequent behavioral deficits in prema
129 n significantly interfere with recovery from brain damage and that mitigation of maladaptive effects
130 bolysis and subsequent reduction of ischemic brain damage and that postischemic helium at 75 vol% red
131 potential to identify specific mechanisms of brain damage and to better target treatment to individua
133 ical symptoms to neuroanatomical profiles of brain damage and ultimately to tissue pathology is a key
134 serious consequences in neonates, provoking brain damage and/or sudden death due to apnea episodes a
136 born very preterm have an increased risk of brain damage, and brain abnormalities which persist into
138 e calculated in and around the site of focal brain damage, and in selected distant and subcortical br
139 these syndromes with the syndromes of acute brain damage, and indicate how the clinical syndromes re
140 ain edema, neutrophil infiltration, ischemic brain damage, and neuronal death in vivo using an adenov
143 egulation defects following focal prefrontal brain damage are associated with exceptionally irrationa
144 eral homonymous visual field disorders after brain damage are frequently associated with a severe imp
145 pression, and recovery of function following brain damage are mediated, in part, by the release of br
146 o are fully conscious and awake, yet, due to brain damage, are unable to show any behavioral responsi
148 e previously observed TBI severity-dependent brain damage as revealed by 2,3,5-triphenyltetrazolium c
149 received mild induced hypothermia to reduce brain damage as suggested by cardiopulmonary resuscitati
151 s with neonatal hypoxic-ischemic and gliotic brain damage, as well as in active multiple sclerosis le
152 is responsible for a substantial fraction of brain damage at early time points after ischemic stroke
154 trauma to determine its effect on secondary brain damage, brain edema formation, and inflammation.
156 onounced inflammatory response that mediates brain damage but is also essential for the tissue repara
157 ch can defend the brain against hypoglycemic brain damage but may aggravate brain damage during ische
158 stroke not only produces local ischemia and brain damage, but also has profound effects on periphera
159 s a potential strategy for treating ischemic brain damage, but high-affinity inhibitors are lacking.
160 or (TNF) is significantly upregulated during brain damage, but it is unknown whether TNF influences s
161 d T cells as important mediators of ischemic brain damage, but the contribution of the different T-ce
162 he observation that inhibition of XO reduces brain damage, but the precise mechanism by which the enz
164 has been proposed to contribute to secondary brain damage by causing pericontusional ischemia, but pr
165 ice are responsible for reducing H/I-induced brain damage by decreasing extracellular glutamate accum
167 at laropiprant treatment post-ICH attenuates brain damage by targeting primary as well as secondary i
172 or performance in rats subjected to ischemic brain damage caused by permanent middle cerebral artery
173 leeds are hypothesized downstream markers of brain damage caused by vascular and amyloid pathologic m
176 d the topological distribution of structural brain damage, defined as post-stroke necrosis or cortica
178 gy with an extended time window for reducing brain damage due to stroke by activating particular PKC
182 hypoglycemic brain damage but may aggravate brain damage during ischemia due to enhanced lactic acid
183 uding Alzheimer's disease, ALS, and ischemic brain damage (elevated d-serine) and schizophrenia (redu
184 l models to link infection, inflammation and brain damage exist, but proof of causation is elusive.
185 to alcohol prenatally may suffer from severe brain damage, expressed as a variety of behavioral probl
186 atients with cerebrovascular accidents where brain damage extends into subcortical white matter.
188 sults were robust to the effects of possible brain damage from suicide attempts, depressive severity,
189 se transmitters with known roles in ischemic brain damage: glutamate, D-serine, ATP and adenosine.
193 ds promise for understanding situations when brain damage impairs normal function or failure to regul
195 totic and anti-excitotoxic actions, reducing brain damage in adult animal models of brain injury.
201 te to the overall burden of vascular-related brain damage in intracerebral haemorrhage, and may be a
205 echniques, we aimed to characterize vascular brain damage in old ApoE(-/-) mice fed a high-cholestero
206 able neuroprotective strategy for minimizing brain damage in premature infants with intraventricular
207 expression of miR-96 significantly prevented brain damage in SE rats by inhibiting Atg7 and Atg16L1 e
209 dingly, we investigated whether NOX-mediated brain damage in stroke can be inhibited by suppression o
211 ia differs from other, more complex types of brain damage in that it appears not to recruit activin A
214 specific emotional deficits following focal brain damage (including fear and the amygdala), and the
215 i) mice exhibit manifestations of kidney and brain damage, including increased plasma urea, impaired
216 level and MR imaging markers of subclinical brain damage, including volumetric, focal, and microstru
218 ese responses may be primarily a reaction to brain damage induced by prion infection rather than spec
219 ion, decorin protected against hydrocephalic brain damage inferred from attenuation of glial and infl
220 urrently available to limit the catastrophic brain damage initiated by the development of intraventri
221 Motor learning and functional recovery from brain damage involve changes in the strength of synaptic
225 tation of dementia, significant irreversible brain damage is already present, rendering the diagnosis
226 demonstrate that the microglial response to brain damage is also TAM-regulated, as TAM-deficient mic
227 to guide the identification of regions where brain damage is likely to cause persistent behavioural e
229 difficult to demonstrate in humans, because brain damage is rarely restricted to this structure.
231 g and understanding rehabilitation following brain damage is whether recovery involves new and aberra
235 ent seizures do not induce the expression of brain damage markers in nonlesional epileptogenic cortex
236 s have recently been raised that subclinical brain damage may occur because of microembolization duri
237 e derangements associated with indicators of brain damage might be indicators of immaturity/vulnerabi
239 ment in spatial navigation in the absence of brain damage, neurological conditions, or basic perceptu
240 us urges, were more likely than smokers with brain damage not involving the insula to undergo a disru
241 d a lower risk of the composite end point of brain damage, nursing home admission, or death (hazard r
242 re relevant to consider treatments to reduce brain damage occurring with transient ischaemic attacks.
243 linicians to answer the question whether the brain damage of the newborn is responsible for its clini
244 patients with semantic impairments following brain damage offer key insights into the cognitive and n
245 viduals with DTD have no apparent structural brain damage on conventional imaging and the neural mech
246 vital importance for assessing the impact of brain damage on function and also for designing rehabili
248 of heart disease, and markers of subclinical brain damage on magnetic resonance (MR) images in commun
250 ral integrity in the left-hemisphere through brain damage or healthy ageing results in increased righ
251 defibrillation were associated with risks of brain damage or nursing home admission and of death from
252 data and reported the 1-year risks of anoxic brain damage or nursing home admission and of death from
253 ed from 2.1% to 16.8% (P<0.001), the rate of brain damage or nursing home admission decreased from 10
254 bystander CPR was associated with a risk of brain damage or nursing home admission that was signific
256 from 2001 through 2012, a total of 10.5% had brain damage or were admitted to a nursing home and 9.7%
257 cannabis in heavy use can cause irreversible brain damage, particularly to adolescents, and thus whet
260 nd cognition critically depends on data from brain-damaged patients since these provide major constra
262 erent control groups, one of which comprised brain-damaged patients with spared ventral cortex (n > 5
265 perfusion therapies, and help prevent subtle brain damage potentially contributing to long-term cogni
269 ink between insomnia and a discrete locus of brain damage, providing novel insight into the neurobiol
274 ith the nonparetic limb following unilateral brain damage results in aberrant synaptogenesis, potenti
278 ral, and motor symptoms linked to cumulative brain damage sustained from single, episodic, or repetit
281 n-fluent aphasia, the current study examined brain damage that negatively influences speech fluency i
282 utions of both Zn(2+) and Ca(2+) in ischemic brain damage, the relative importance of each cation to
283 Given the recognized role of INa in hypoxic brain damage, the SUMO pathway and NaV1.2 are identified
284 sient insults to brain may lead to long-term brain damage, these findings suggest that isoflurane may
285 al ischemia and reperfusion is implicated in brain damage through different cellular and molecular me
286 n-symptom mapping in 241 patients with focal brain damage to investigate their neural underpinnings.
288 xecutive function in 182 patients with focal brain damage using voxel-based lesion-symptom mapping.
289 l substrates of g in 241 patients with focal brain damage using voxel-based lesion-symptom mapping.
291 flammation outcomes were assessed at 72 hrs; brain damage was assessed at 2 wks and 6 wks along with
293 significance of severe hypoglycemia-induced brain damage was evaluated by motor and cognitive testin
295 h P301L mutation also affects stroke-induced brain damage, we performed hypoxia/ischemia (H/I) in you
296 ia-reoxygenation injury and reduces ischemic brain damage when injected up to 6 h after the insult.
297 sive neuronal death and BBB leakage indicate brain damage, which is further supported by extensive mi
298 d hypohaptoglobinemia aggravates ICH-induced brain damage while pharmacologic intervention with sulfo
299 ain parenchyma, and they respond promptly to brain damage with targeted process movement toward the i
300 minutes after complete occlusion and reduced brain damage without inducing hemorrhage, whereas tirofi
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。